PLCG2 and Netherton syndrome: With a known role in intracellular calcium regulation, it is plausible that PLCG2 variants may directly contribute to podocyte injury, especially with the discovery of variants in a related PLC enzyme, PLCE1, as a cause of NS with variable therapy response (Figure 1) (66).